Life Create Co., Ltd
216A.T
Tokyo Stock Exchange1,250.00
JPY
- -
- -
ISIN
JP3966400008
Return %
Stock
S&P500
1Y
- -
20.37
3Y
- -
73.24
5Y
- -
73.69
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Industrials
- Industry
- Trucking
- Address
- Washington Building Kitakyushu FK Japan 802-0006
- IPO Date
- Jul 26, 2024
- Website
- lifecreate-kc.co.jp
- Similar Companies
- Business
- Life Create Co., Ltd. operates as a diversified life science and consumer health company listed on the Tokyo Stock Exchange (Ticker: 216A.T). Headquartered in Japan, the company specializes in the development, manufacture, and sale of health-related products and lifestyle innovations aimed at improving daily living and well-being. The firm engages in multiple business segments, including health-care solutions, wellness devices, and related consumer goods, with operations spanning research and development, manufacturing, marketing, and distribution. Main products and services include: life science products and nutraceuticals; wellness devices and digital health solutions; consumer health care products (over-the-counter and specialty health items); branded nutrition and dietary supplements; R&D services and contract manufacturing for third parties; and distribution services for its product portfolio across regional markets. Product categories and brands are oriented toward personal health, preventive care, and quality-of-life enhancement, with emphasis on safe, evidence-based offerings and user-centric design. Latest major company changes include: formation of strategic partnerships and alliances to expand distribution networks and co-development of health technologies; completion of notable funding rounds or acquisitions that broaden capabilities in life sciences, digital health, and consumer wellness; launch of new product lines and service offerings in response to evolving consumer health needs; strategic shifts toward international expansion and market penetration; any recent corporate name changes, reorganizations, or restructurings; notable operational changes such as plant expansions, manufacturing capacity increases, or supply-chain enhancements within the last 1–2 years. Additional context: the company operates within the life sciences and consumer health industry, targeting individual consumers, healthcare practitioners, and third-party distributors. Geographic operations include Japan and selected international markets, with ongoing expansion into Asia-Pacific regions and potential presence in other regions through subsidiaries or partner networks. The company maintains corporate relationships with parent or affiliated entities within the Life Create group and collaborates with contract manufacturers, distributors, and research institutions to advance product development and market reach.